Controversial Diabetes Drug Harms Heart, U.S. Concludes
The Reports, Obtained by The New York Times, say that if every now diabetic taking Avandia were instead given a similar pill named Actos, about 500 heart attacks and 300 cases of heart failure would be averted every month "Because Avandia can hurt the heart. Avandia, intended to treat Type 2 diabetes, is known as rosiglitazone and was Linked to 304 deaths during the third quarter of 2009.
"Rosiglitazone should be removed from the market," one report, by Dr. David Graham and Dr. Kate Gelperin of the Food and Drug Administration, concludes. Both authors recommended that Avandia be withdrawn.
The internal F.D.A. Reports are part of a fierce debate within the agency over what to do about Avandia, manufactured by GlaxoSmithKline. Some agency officials want the drug withdrawn Because they believe there is a safer alternative, others insist that studies of the drug provide contradictory information and that Avandia should continue to be an option for doctors and patients. GlaxoSmithKline said that it had extensively studied Avandia and that "scientific evidence simply does not Establish that Avandia increases" the risk of heart attacks.Read More Story,http://www.nytimes.com/2010/02/20/health/policy/20avandia.html
0 comments:
Post a Comment